The RayPlex Atezolizumab (Tecentriq®) ADA kit is a cytometric bead assay to quantitatively measure Atezolizumab (Tecentriq®) antibodies by flow cytometry. The assay has been optimized for serum and plasma.
The RayPlex Infliximab (Remicade®) ADA kit is a cytometric bead assay to quantitatively measure Infliximab (Remicade®) antibodies by flow cytometry. The assay has been optimized for serum and plasma.
The RayPlex Obinutuzumab (Gazyva®) ADA kit is a cytometric bead assay to quantitatively measure Obinutuzumab (Gazyva®) antibodies by flow cytometry. The assay has been optimized for serum and plasma.
The RayPlex Omalizumab (Xolair®) ADA kit is a cytometric bead assay to quantitatively measure Omalizumab (Xolair®) antibodies by flow cytometry. The assay has been optimized for serum and plasma.
The RayPlex Pembrolizumab (Keytruda®) ADA kit is a cytometric bead assay to quantitatively measure Pembrolizumab (Keytruda®) antibodies by flow cytometry. The assay has been optimized for serum and plasma.
The RayPlex Ranibizumab (Lucentis®) ADA kit is a cytometric bead assay to quantitatively measure Ranibizumab (Lucentis®) antibodies by flow cytometry. The assay has been optimized for serum and plasma.
The RayPlex Rituximab ADA kit is a cytometric bead assay that quantitatively detects anti-drug antibodies by flow cytometry. Suitable for serum and plasma.
The RayPlex Sarilumab (Kevzara®) ADA kit is a cytometric bead assay to quantitatively measure Sarilumab (Kevzara®) antibodies by flow cytometry. The assay has been optimized for serum and plasma.
